Azithromycin, an antibiotic used to treat COVID-19, was no more effective at freeing non-hospitalized patients of COVID-19 symptoms than a placebo, a study found. Findings from researchers affiliated ...

Azithromycin is an antibiotic drug. It can help treat a range of bacterial infections that affect the lungs, sinuses, skin, and other parts of the body. Learn about its uses, risks, side effects, and ...

Zithromax azithromycin, also known as Z-Pak, is an antibiotic approved for treatment of respiratory, skin and other bacterial infections. Studies link the drug to side effects, including an increased ...

Antibiotics for pneumonia include Zithromax (azithromycin), Biaxin (clarithromycin), and Erythrocin (erythromycin). Azithromycin is often the first-line treatment since it is effective against many ...

According to a recent large, multi-country clinical trial, the risk of postpartum sepsis and death in women who plan to deliver vaginally can be reduced by one-third by administering a single dose of ...

According to investigators, clinicians need to weigh the antimicrobial benefits of azithromycin, levofloxacin, and amoxicillin-based antibiotics against their potential cardiac risks in the ...

Zithromax azithromycin, also known as Z-Pak, is an antibiotic approved for treatment of respiratory, skin and other bacterial infections. Studies link the drug to side effects, including an increased ...

The U.S. Food and Drug Administration (FDA) has issued a warning that the antibiotic azithromycin (Zithromax or Zmax) can cause abnormal changes in the electrical activity of the heart that may lead ...

A recent national analysis showed that 27% of U.S. patients diagnosed with COVID-19 in late 2020 received prescriptions for azithromycin, commonly known as the “Z-Pak.” This occurred even though there ...

An inexpensive and easy-to-deliver intervention — a single dose of the antibiotic azithromycin — could sharply reduce the number of pregnant people in low- and middle-income countries who develop the ...

Please provide your email address to receive an email when new articles are posted on . PHOENIX — Azithromycin failed to prevent infants with severe respiratory syncytial virus, or RSV, from later ...

Azithromycin appears to significantly increase patients’risk for sudden cardiac death compared with patients taking no antibiotics,results of an analysis reveal. The hazard ratio for cardiovascular ...